Erratum to: “Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis,” by Pollak et al. (Biol Psychiatry 2021; 90:9-15); https://doi.org/10.1016/j.biopsych.2020.11.014.
An astute reader noticed an error in the final paragraph of the Results section for this paper. Specifically, the serostatus terms were inadvertently reversed in the following sentence: “There was no association between frequency of remission and serostatus, with remission occurring in 196 (69.3%) seropositive patients and 9 (81.8%) seronegative patients (p = .394).” The corrected sentence reads: “There was no association between frequency of remission and serostatus, with remission occurring in 196 (69.3%) seronegative patients and 9 (81.8%) seropositive patients (p = .394).” The authors emphasize that the difference remains nonsignificant with no change to the significance value and the results are not influenced by this typographical error in any way.
This error has been corrected in the final paginated version of this article.
Article info
Identification
Copyright
© 2021 Society of Biological Psychiatry.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisBiological PsychiatryVol. 90Issue 1
- PreviewWhen psychosis develops in NMDA receptor (NMDAR) antibody encephalitis, it usually has an acute or subacute onset, and antipsychotic treatment may be ineffective and associated with adverse effects. Serum NMDAR antibodies have been reported in a minority of patients with first-episode psychosis (FEP), but their role in psychosis onset and response to antipsychotic treatment is unclear.
- Full-Text
- Preview
